142 related articles for article (PubMed ID: 10903478)
1. The capacity of various non-esterified fatty acids to suppress lipid transfer inhibitor protein activity is related to their perturbation of the lipoprotein surface.
Morton RE; Greene DJ
Biochim Biophys Acta; 2000 Jul; 1486(2-3):275-84. PubMed ID: 10903478
[TBL] [Abstract][Full Text] [Related]
2. Suppression of lipid transfer inhibitor protein activity by oleate. A novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids.
Morton RE; Greene DJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3041-8. PubMed ID: 9409291
[TBL] [Abstract][Full Text] [Related]
3. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.
Serdyuk AP; Morton RE
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):718-26. PubMed ID: 10073979
[TBL] [Abstract][Full Text] [Related]
4. Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).
Paromov VM; Morton RE
J Biol Chem; 2003 Oct; 278(42):40859-66. PubMed ID: 12907677
[TBL] [Abstract][Full Text] [Related]
5. CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL.
Morton RE; Greene DJ
J Lipid Res; 2003 Dec; 44(12):2287-96. PubMed ID: 12951364
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F.
Wang X; Driscoll DM; Morton RE
J Biol Chem; 1999 Jan; 274(3):1814-20. PubMed ID: 9880564
[TBL] [Abstract][Full Text] [Related]
7. Effects of various non-esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein.
Lagrost L; Barter PJ
Biochim Biophys Acta; 1991 Sep; 1085(2):209-16. PubMed ID: 1892890
[TBL] [Abstract][Full Text] [Related]
8. Markedly elevated lipid transfer inhibitor protein in hypercholesterolemic subjects is mitigated by plasma triglyceride levels.
Morton RE; Nunes V; Izem L; Quintão E
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1642-9. PubMed ID: 11597939
[TBL] [Abstract][Full Text] [Related]
9. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome.
Braschi S; Masson D; Rostoker G; Florentin E; Athias A; Martin C; Jacotot B; Gambert P; Lallemant C; Lagrost L
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2559-67. PubMed ID: 9409228
[TBL] [Abstract][Full Text] [Related]
10. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma.
Lagrost L; Florentin E; Guyard-Dangremont V; Athias A; Gandjini H; Lallemant C; Gambert P
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1388-96. PubMed ID: 7670953
[TBL] [Abstract][Full Text] [Related]
11. Effects of various non-esterified fatty acids on the particle size redistribution of high density lipoproteins induced by the human cholesteryl ester transfer protein.
Lagrost L; Barter PJ
Biochim Biophys Acta; 1991 Mar; 1082(2):204-10. PubMed ID: 2007183
[TBL] [Abstract][Full Text] [Related]
12. Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes.
Morton RE; Greene DJ
J Lipid Res; 1994 May; 35(5):836-47. PubMed ID: 8071606
[TBL] [Abstract][Full Text] [Related]
13. The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins.
Barter PJ; Chang LB; Newnham HH; Rye KA; Rajaram OV
Biochim Biophys Acta; 1990 Jun; 1045(1):81-9. PubMed ID: 2369588
[TBL] [Abstract][Full Text] [Related]
14. Determination of lipid transfer inhibitor protein activity in human lipoprotein-deficient plasma.
Morton RE; Steinbrunner JV
Arterioscler Thromb; 1993 Dec; 13(12):1843-51. PubMed ID: 8241106
[TBL] [Abstract][Full Text] [Related]
15. Alterations of lipoprotein fluidity by non-esterified fatty acids known to affect cholesteryl ester transfer protein activity. An electron spin resonance study.
Foucher C; Lagrost L; Maupoil V; le Meste M; Rochette L; Gambert P
Eur J Biochem; 1996 Mar; 236(2):436-42. PubMed ID: 8612613
[TBL] [Abstract][Full Text] [Related]
16. Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase.
Newnham HH; Barter PJ
Biochim Biophys Acta; 1992 May; 1125(3):297-304. PubMed ID: 1596518
[TBL] [Abstract][Full Text] [Related]
17. Enhanced detection of lipid transfer inhibitor protein activity by an assay involving only low density lipoprotein.
Morton RE; Greene DJ
J Lipid Res; 1994 Nov; 35(11):2094-9. PubMed ID: 7868987
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein reaction between plasma lipoproteins.
Main LA; Okumura-Noji K; Ohnishi T; Yokoyama S
J Biochem; 1998 Jul; 124(1):237-43. PubMed ID: 9644269
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of cis and trans fatty acid isomers, oleic and elaidic acids, on the cholesteryl ester transfer protein activity.
Lagrost L
Biochim Biophys Acta; 1992 Mar; 1124(2):159-62. PubMed ID: 1543738
[TBL] [Abstract][Full Text] [Related]
20. Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.
Morton RE; Greene DJ
J Lipid Res; 2011 Dec; 52(12):2262-2271. PubMed ID: 21937674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
